Clinical Trials Directory

Trials / Completed

CompletedNCT00455832

Influence of Ribavirin and Interferon on Semen Quality, IRIS Study

Status
Completed
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
Foundation for Liver Research · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to study the effect of peginterferon alpha and ribavirin on spermatozoa.

Detailed description

During and six months after treatment with peginterferon alpha and ribavirin strict use of birth control is recommended (the producers advice two reliable forms) for both men and women because ribavirin has teratogenic and/or embryo-lethal effects in animal studies. In cases of pregnancies during paternal exposure to peginterferon alpha and ribavirin elective termination of the pregnancy is usually recommended. However three cases of births after paternal exposure are reported with no birth defects. Cases of abnormalities after paternal exposure to ribavirin are lacking. Also studies on the influence of ribavirin on sperm in human are lacking. The aim of this study is to study the effect of peginterferon alpha and ribavirin on spermatozoa in men using these medication.

Conditions

Interventions

TypeNameDescription
PROCEDUREpeginterferon alpha and ribavirinsperm collection

Timeline

Start date
2006-11-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2007-04-04
Last updated
2012-02-29

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00455832. Inclusion in this directory is not an endorsement.